Clinical pathway for peritoneal carcinomatosis from colon and rectal cancer: Guidelines for current practice

A. G. Portilla, M. Deraco, P. H. Sugarbaker

Research output: Contribution to journalArticle

Abstract

Peritoneal carcinomatosis from colon and rectal cancer was in the past a terminal condition without curative treatment options. Recently an aggressive treatment strategy has resulted in long-term survival in a select group of patients with this condition. The sequence of diagnostic tests and treatments for these patients are presented in a chronological order as a clinical pathway. This exposition is to provide a standardized management plan that will allow critical evaluation of the morbidity, mortality outcomes and cost of this protracted plan of patient care. The discipline that the clinical pathway process demands may facilitate the continued optimization of this treatment strategy.

Original languageEnglish
Pages (from-to)725-728
Number of pages4
JournalTumori
Volume83
Issue number4
Publication statusPublished - 1997

Keywords

  • 5-fluorouracil
  • Colon cancer
  • Heated intraperitoneal chemotherapy
  • Hyperthermia
  • Mitomycin
  • Peritoneal carcinomatosis
  • Peritonectomy

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Clinical pathway for peritoneal carcinomatosis from colon and rectal cancer: Guidelines for current practice'. Together they form a unique fingerprint.

  • Cite this